A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus
NCT01707147
·
clinicaltrials.gov ↗
COMPLETED
Status
3219
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Trajenta tablet
Sponsor
Boehringer Ingelheim
Collaborators
[object Object]